Peter Mueller

2013

In 2013, Peter Mueller earned a total compensation of $4.2M as EVP, Global R&D Chief Scientific Officer at Vertex Pharmaceuticals, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$637,000
Option Awards$2,361,640
Salary$619,846
Stock Awards$544,988
Other$12,675
Total$4,176,149

Mueller received $2.4M in option awards, accounting for 57% of the total pay in 2013.

Mueller also received $637K in non-equity incentive plan, $619.8K in salary, $545K in stock awards and $12.7K in other compensation.

Rankings

In 2013, Peter Mueller's compensation ranked 1,646th out of 12,286 executives tracked by ExecPay. In other words, Mueller earned more than 86.6% of executives.

ClassificationRankingPercentile
All
1,646
out of 12,286
87th
Division
Manufacturing
543
out of 4,612
88th
Major group
Chemicals And Allied Products
146
out of 1,462
90th
Industry group
Drugs
98
out of 1,156
92nd
Industry
Pharmaceutical Preparations
86
out of 890
90th
Source: SEC filing on March 28, 2014.

Mueller's colleagues

We found four more compensation records of executives who worked with Peter Mueller at Vertex Pharmaceuticals in 2013.

2013

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2013

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2013

Kenneth Horton

Vertex Pharmaceuticals

Chief Legal Officer

2013

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

In-depth

You may also like